SuperGen, Inc. SUPG, a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies, announced that Eisai Inc.
today released information that the U.S. Food and Drug Administration
has accepted for review its supplemental New Drug Application seeking
approval of DACOGEN for injection in the treatment of acute
myeloid leukemia. Acute myeloid leukemia is a life-threatening cancer of
the blood for which there are few treatment options.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in